These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9657156)

  • 1. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion.
    DePace AH; Santoso A; Hillner P; Weissman JS
    Cell; 1998 Jun; 93(7):1241-52. PubMed ID: 9657156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion.
    Osherovich LZ; Weissman JS
    Cell; 2001 Jul; 106(2):183-94. PubMed ID: 11511346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting the structural basis of prion strains: induction and identification of [PSI] variants.
    King CY
    J Mol Biol; 2001 Apr; 307(5):1247-60. PubMed ID: 11292339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of prion transmission barriers by mutational control of amyloid conformations.
    Chien P; DePace AH; Collins SR; Weissman JS
    Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions.
    Parham SN; Resende CG; Tuite MF
    EMBO J; 2001 May; 20(9):2111-9. PubMed ID: 11331577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein.
    Chernoff YO; Galkin AP; Lewitin E; Chernova TA; Newnam GP; Belenkiy SM
    Mol Microbiol; 2000 Feb; 35(4):865-76. PubMed ID: 10692163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins.
    Halfmann R; Alberti S; Krishnan R; Lyle N; O'Donnell CW; King OD; Berger B; Pappu RV; Lindquist S
    Mol Cell; 2011 Jul; 43(1):72-84. PubMed ID: 21726811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Candida albicans Sup35p protein (CaSup35p): function, prion-like behaviour and an associated polyglutamine length polymorphism.
    Resende C; Parham SN; Tinsley C; Ferreira P; Duarte JAB; Tuite MF
    Microbiology (Reading); 2002 Apr; 148(Pt 4):1049-1060. PubMed ID: 11932450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Yarrowia lipolytica orthologs of Sup35p assemble into thioflavin T-negative amyloid fibrils.
    Kabani M; Melki R
    Biochem Biophys Res Commun; 2020 Aug; 529(3):533-539. PubMed ID: 32736670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting yeast and mammalian prion aggregation kinetic data with the Finke-Watzky two-step model of nucleation and autocatalytic growth.
    Watzky MA; Morris AM; Ross ED; Finke RG
    Biochemistry; 2008 Oct; 47(40):10790-800. PubMed ID: 18785757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of the asparagine- and glutamine-rich yeast prions into protein fibrils.
    Bousset L; Savistchenko J; Melki R
    Curr Alzheimer Res; 2008 Jun; 5(3):251-9. PubMed ID: 18537542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of conformational flexibility in prion propagation and maintenance for Sup35p.
    Scheibel T; Lindquist SL
    Nat Struct Biol; 2001 Nov; 8(11):958-62. PubMed ID: 11685242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation.
    Alexandrov IM; Vishnevskaya AB; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2008 May; 283(22):15185-92. PubMed ID: 18381282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into intragenic and extragenic effectors of prion propagation using chimeric prion proteins.
    True HL; Kalastavadi T; Tank EM
    Prion; 2008; 2(2):45-7. PubMed ID: 19098443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prions of yeast as heritable amyloidoses.
    Wickner RB; Taylor KL; Edskes HK; Maddelein ML; Moriyama H; Roberts BT
    J Struct Biol; 2000 Jun; 130(2-3):310-22. PubMed ID: 10940235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct amino acid compositional requirements for formation and maintenance of the [PSI⁺] prion in yeast.
    MacLea KS; Paul KR; Ben-Musa Z; Waechter A; Shattuck JE; Gruca M; Ross ED
    Mol Cell Biol; 2015 Mar; 35(5):899-911. PubMed ID: 25547291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scrambled prion domains form prions and amyloid.
    Ross ED; Baxa U; Wickner RB
    Mol Cell Biol; 2004 Aug; 24(16):7206-13. PubMed ID: 15282319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could yeast prion domains originate from polyQ/N tracts?
    Alexandrov AI; Ter-Avanesyan MD
    Prion; 2013; 7(3):209-14. PubMed ID: 23764835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.